UCHL1 and Alzheimer disease: Consistently with these observations, proteomic analyses carried out by several research groups identified an AD-driven increase in UCH-L1 in the CSF, with no statistically significant increase observed in other non-AD neurological diseases [103], or in a combined groups of participants with MCI or AD diagnoses [104].